Chromosomal abnormalities in untreated patients with non-Hodgkin's lymphoma: associations with histology, clinical characteristics, and treatment outcome. The Nebraska Lymphoma Study Group.

We describe the chromosomal abnormalities found in 104 previously untreated patients with non-Hodgkin's lymphoma (NHL) and the correlations of these abnormalities with disease characteristics. The cytogenetic method used was a 24- to 48-hour culture, followed by G-banding. Several significant associations were discovered. A trisomy 3 was correlated with high-grade NHL. In the patients with an immunoblastic NHL, an abnormal chromosome no. 3 or 6 was found significantly more frequently. As previously described, a t(14;18) was significantly correlated with a follicular growth pattern. Abnormalities on chromosome no. 17 were correlated with a diffuse histology and a shorter survival. A shorter survival was also correlated with a +5, +6, +18, all abnormalities on chromosome no. 5, or involvement of breakpoint 14q11-12. In a multivariate analysis, these chromosomal abnormalities appeared to be independent prognostic factors and correlated with survival more strongly than any traditional prognostic variable. Patients with a t(11;14)(q13;q32) had an elevated lactate dehydrogenase (LDH). Skin infiltration was correlated with abnormalities on 2p. Abnormalities involving breakpoints 6q11-16 were correlated with B symptoms. Patients with abnormalities involving breakpoints 3q21-25 and 13q21-24 had more frequent bulky disease. The correlations of certain clinical findings with specific chromosomal abnormalities might help unveil the pathogenetic mechanisms of NHL and tailor treatment regimens.

[1]  M. Oken,et al.  bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma. , 1989, The New England journal of medicine.

[2]  D. Weisenburger,et al.  Initial and subsequent cytogenetic studies in malignant lymphoma , 1987, Cancer.

[3]  D. Weisenburger,et al.  Chromosomal abnormalities in indolent lymphoma. , 1987, Cancer genetics and cytogenetics.

[4]  J. Ranstam,et al.  Prognostic implication of cytogenetic findings in 106 patients with non-Hodgkin lymphoma. , 1987, Cancer genetics and cytogenetics.

[5]  M. Oken,et al.  Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer. , 1987, The New England journal of medicine.

[6]  C. Bloomfield,et al.  Correlations between immunological phenotype and karyotype in malignant lymphoma. , 1986, Cancer research.

[7]  F. Mitelman,et al.  Chromosome abnormalities in the myelodysplastic syndromes. , 1986, Clinics in haematology.

[8]  G. Juliusson Immunologic and cytogenetic studies improve prognosis prediction in chronic B‐lymphocytic leukemia a multivariate analysis of 24 variables , 1986, Cancer.

[9]  D. Weisenburger,et al.  Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissions. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  G. Gahrton,et al.  Abnormal/normal metaphase ratio and prognosis in chronic B-lymphocytic leukemia. , 1985, Cancer genetics and cytogenetics.

[11]  C. Bloomfield,et al.  There are differences in cytogenetic abnormalities among histologic subtypes of the non-Hodgkin's lymphomas , 1985 .

[12]  E. Henderson,et al.  Cytogenetic studies in 77 patients with chronic lymphocytic leukemia: correlations with clinical, immunologic, and phenotypic data. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  E. Henderson,et al.  Prognostic importance of cytogenetic abnormalities in patients with chronic lymphocytic leukemia. , 1984, The New England journal of medicine.

[14]  J. Rowley,et al.  Prognostic implications of karyotype and morphology in patients with non‐Hodgkin's lymphoma , 1983, International journal of cancer.

[15]  C. Bloomfield,et al.  Nonrandom chromosome abnormalities in lymphoma. , 1983, Cancer research.

[16]  J. Rowley,et al.  A collaborative study of the relationship of the morphological type of acute nonlymphocytic leukemia with patient age and karyotype. , 1982, Blood.

[17]  Y. Kaneko,et al.  An analysis of chromosome findings in non-Hodgkin's lymphomas. , 1982, Cancer genetics and cytogenetics.

[18]  J. Fleiss,et al.  Statistical methods for rates and proportions , 1973 .

[19]  M Tubiana,et al.  Report of the Committee on Hodgkin's Disease Staging Classification. , 1971, Cancer research.

[20]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[21]  C. Bloomfield,et al.  Cytogenetic abnormalities predict clinical outcome in non-Hodgkin lymphoma. , 1988, Annals of internal medicine.

[22]  Correlation of Chromosome Abnormalities With Histologic and Immunologic Characteristics in Non-Hodgkin ’ s Lymphoma and Adult , 2022 .

[23]  S. Jhanwar,et al.  Cytogenetic and histologic correlations in malignant lymphoma. , 1987, Blood.

[24]  Walker,et al.  Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. , 1986, Blood.

[25]  L. Zech,et al.  Prognostic information from cytogenetic analysis in chronic B-lymphocytic leukemia and leukemic immunocytoma. , 1985, Blood.

[26]  C. Bloomfield,et al.  There are differences in cytogenetic abnormalities among histologic subtypes of the non-Hodgkin's lymphomas. , 1985, Blood.

[27]  Iscn International System for Human Cytogenetic Nomenclature , 1978 .

[28]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .

[29]  P. Nowell,et al.  A minute chromosome in human chronic granulocytic leukemia , 1960 .